<qa>  What is the primary goal of Stage II?Stage II is multi-center, parallel-group, double-blind,phase III study to evaluate the efficacy and safety of once per cycle GCPGC in chemotherapy-induced neutropenia compared to Neulasta pegfilgrastim. A total of 120 patients receiving chemotherapy will participate into this phase. 